HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of severe hepatitis with infliximab in adult-onset Still's disease.

AuthorsBhavneet Singh, John Biboa, Sunitha Musuku, Charmi Patel, Judith L Pugh, Thomas D Boyer
JournalThe American journal of medicine (Am J Med) Vol. 126 Issue 2 Pg. e3-4 (Feb 2013) ISSN: 1555-7162 [Electronic] United States
PMID23331455 (Publication Type: Case Reports, Letter)
Chemical References
  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Methylprednisolone Hemisuccinate
  • Infliximab
Topics
  • Adrenal Cortex Hormones (administration & dosage, therapeutic use)
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Female
  • Hepatitis (drug therapy)
  • Humans
  • Infliximab
  • Methylprednisolone Hemisuccinate (administration & dosage, therapeutic use)
  • Still's Disease, Adult-Onset (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: